DiarioFarma. On November 3, Biosim, the association that brings together 100% of the companies with interests in biosimilar medicines, was presented in society. Once the project is underway, its president, Joaquín Rodrigo, explains to Diariofarma the keys and the needs of these medicines to be able to contribute both in the short and long term their main advantages and reasons for being: accessibility and sustainability. Rodrigo calls for biosimilars to be taken as a long-distance race to ensure that it continues to be profitable to develop them in the future and that the system and patients benefit from these products for a long time.

READ MORE